<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rizzo, Toni</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Cho, Steve Y.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">The Crucial Role of Imaging for Response-Adapted Management of Lymphoma</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-02-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">17-18</style></pages><abstract><style  face="normal" font="default" size="100%">Computed tomography (CT) is the gold standard for assessing lymphoma response to therapy. This session addressed the role of imaging in guiding the treatment of patients with Hodgkin lymphoma and non-Hodgkin lymphoma, with a focus on the use of positron emission tomography/CT for response evaluation.</style></abstract><number><style face="normal" font="default" size="100%">53</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>